Zemplar (paricalcitol) 1 mcg Capsule Recall: Content Uniformity Issue
AbbVie recalls Zemplar capsules due to failed content uniformity. Check lot #1055586 and NDC 0074-4317-30 for affected units.
Use caution until it’s fixed
Failed Content Uniformity Specifications
Contact the company
What happened, in plain English
AbbVie Inc. has recalled one lot of Zemplar (paricalcitol) capsules, 1 mcg, in 30-count bottles. The recall is necessary because the product failed content uniformity specifications, meaning the amount of active ingredient may not be consistent across all pills. This affects patients relying on a precise dose for their treatment. Read more at govinfonow.com/recall/43097-zemplar-paricalcitol-1-mcg-capsule-recall-content-uniformity-issue.
Source Summary by GovInfoNow · govinfonow.com/recall/43097-zemplar-paricalcitol-1-mcg-capsule-recall-content-uniformity-issue · Updated October 11, 2026 · FDA enforcement record: FDA #D-0833-2016
Cite this page
“Zemplar (paricalcitol) 1 mcg Capsule Recall: Content Uniformity Issue.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/43097-zemplar-paricalcitol-1-mcg-capsule-recall-content-uniformity-issue. Based on FDA recall #D-0833-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0833-2016%22&limit=1).
Why it’s dangerous
The capsules failed content uniformity specifications. This means the amount of paricalcitol in each capsule might vary from the labeled amount, potentially leading to under-dosing or over-dosing if consumed without medical supervision.
Who’s affected
Patients currently taking Zemplar (paricalcitol) capsules prescribed by a healthcare provider. Specifically, those who have the affected lot number or purchased the product before the recall date.
How to tell if you have this one
Check your medication bottle for NDC 0074-4317-30 and Lot #1055586. The product is Zemplar (paricalcitol) capsules, 1 mcg, in a 30-count bottle.
- Brand
Zemplar- Category
Drug
What to do — step by step
Contact Your Pharmacist
Inform your pharmacist or healthcare provider that you have the recalled lot of Zemplar capsules so they can advise you on next steps and replacement.
Do Not Stop Medication Abruptly
Consult your doctor before stopping or changing your medication regimen, as sudden changes may affect your health condition.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 7 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
What is the NDC for the recalled product?
The National Drug Code (NDC) is 0074-4317-30.
How many bottles are being recalled?
Approximately 307 bottles are included in this recall.
Similar recalls
Other Zemplar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0833-2016 (March 24, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0833-2016 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.